Product
EVX-01
1 clinical trial
2 indications
Indication
Melanoma stage IIIIndication
melanomaClinical trial
An Open Label, Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Checkpoint Inhibitor Treatment naïve Adults With Unresectable or Metastatic MelanomaStatus: Recruiting, Estimated PCD: 2025-06-28